Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering......

Drug major Novartis has been slapped with a Rs 300-crore (Rs 3 billion) penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine. The Swiss......

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......